GLP

Bio & Pharma Kobiolabs gets Chinese patent for obesity treatment strain

South Korean microbiome-based new drug development company Kobiolabs Co. announced on Wednesday that it has a patent for its obesity treatment strai...

Bio & Pharma Hanmi Pharm to develop obesity drug customized for S.Korean

South Korea's Hanmi Pharmaceutical Co. plans to develop the GLP-1 class "Epeglenatide," which it received as a technology return from Sanofi S.A., i...

Real estate IGIS beats Blackstone, Brookfield in Asian real estate AUM

IGIS Asset Management Co., South Korea’s largest real estate asset manager, was ranked as the world’s second-largest asset management ...

Artificial intelligence NPS, KIC commit $600 mn to N.America logistics fund

The National Pension Service (NPS) and the Korea Investment Corporation (KIC) have committed $600 million in aggregate to GLP Capital Partners' Nort...